Moderna's COVID-19 vaccine 'Spikevax' received full approval from the U.S. Food and Drug Administration (FDA), after more than a year of its "emergency use authorization", reported USA TODAY.
Chile on Monday began vaccinating children aged 6 to 11 against COVID-19 with the CoronaVac vaccine, developed by Chinese pharmaceutical company Sinovac.
